Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Lisinopril Market Revenue Growth Supported By A CAGR Of 2.46% Through 2030
The lisinopril market experienced robust expansion historically, projecting a rise from $1.87 billion in 2025 to $1.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. This recent growth trajectory is largely underpinned by an escalating prevalence of hypertension, the established and widespread clinical trust in ACE inhibitors, a steadily aging demographic, its early integration into heart failure management protocols, and an improved reach of primary healthcare services.
The lisinopril market is poised for significant expansion over the coming years, projecting a valuation of $2.47 billion by 2030, underpinned by a compound annual growth rate (CAGR) of 5.5%. This anticipated growth trajectory is fueled by several key factors, including the escalating prevalence of cardiovascular ailments, an increasing consumer preference for cost-effective generic medications, a heightened emphasis on proactive cardiac health initiatives, the broadened application of lisinopril in managing diabetic nephropathy, and augmented healthcare expenditure directed towards the management of persistent health conditions. Furthermore, emerging trends anticipated to shape this market during the forecast period encompass a greater incidence of hypertension and cardiovascular irregularities, a growing tendency to prescribe ACE inhibitors as initial treatments, a wider adoption of generic lisinopril formulations, its elevated utilization in the aftermath of myocardial infarctions, and improved patient compliance over extended treatment durations for chronic conditions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp
Lisinopril Market Industry Drivers: What Is Driving Revenue Growth?
The expanding incidence of heart and circulatory conditions is anticipated to fuel the advancement of the lisinopril market, as these ailments are becoming more common. Such conditions, affecting the heart and blood vessels, are on the rise due to factors including an increasing and aging global population, the presence of risk-promoting behaviors, and insufficient application of established preventive and therapeutic approaches. Lisinopril plays a crucial role in managing these cardiovascular issues, primarily by reducing blood pressure and thereby alleviating stress on the heart and kidneys. It achieves this by obstructing angiotensin II production, promoting blood vessel widening, decreasing blood volume, and shielding vital organs from harm. For illustration, data from May 2024 published by the Singapore Heart Foundation indicated that ischemic heart diseases were responsible for 5,302 fatalities, a marginal rise from the 5,290 deaths recorded in 2022, underscoring the growing burden of cardiovascular diseases which, in turn, fuels the lisinopril market.
The escalating occurrence of hypertension is projected to be a key catalyst for the expansion of the lisinopril market. This condition, characterized by persistently elevated blood pressure within the arteries, is becoming more widespread owing to lifestyle factors such as poor dietary habits, lack of physical activity, demographic shifts towards older age groups, and chronic stress. Lisinopril is instrumental in controlling hypertension by impeding the creation of angiotensin II, which results in relaxed blood vessels, a diminished blood volume, and consequently, lower blood pressure. To provide context, the World Health Organization reported in March 2023 that approximately 1.28 billion adults globally between the ages of 30 and 79 years suffered from hypertension that year, highlighting the significant public health challenge that this condition presents and its direct impact on the lisinopril market’s growth.
Lisinopril Market Segmentation: How Is The Market Structured Across Key Categories?
The lisinopril market covered in this report is segmented –
1) By Brand: Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack
3) By Dosage: Tablet, Liquid
4) By End-Users: Hospitals, Specialty Clinics
Subsegments:
1) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil
2) By Zestril: Different Dosage Forms, Generic Versions Of Zestril
3) By Other Brands: International Brand Variants, Combination Drug Formulations
Lisinopril Market Competitive Landscape And Leading Companies
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH
Access The Complete Lisinopril Market Report:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report
Lisinopril Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the lisinopril market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
